ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force …
SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier
The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …
make recommendations about appropriate use of technology for the diagnosis and …
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II
TF Lüscher, MA Creager, JA Beckman, F Cosentino - Circulation, 2003 - Am Heart Assoc
Diabetes and Vascular Disease | Circulation Science Volunteer Warning signs SearchSearch
Advanced Search Donate Circulation logo Hello Guest! MY ALERTS SIGN IN JOIN …
Advanced Search Donate Circulation logo Hello Guest! MY ALERTS SIGN IN JOIN …
Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
S Silber, P Albertsson, FF Avilés… - European heart …, 2005 - academic.oup.com
In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …
revascularization in all patients with objective large ischaemia in the presence of almost …
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic …
SD Wiviott, E Braunwald, DJ Angiolillo, S Meisel… - Circulation, 2008 - Am Heart Assoc
Background—Patients with diabetes mellitus (DM) are at high risk for recurrent
cardiovascular events after acute coronary syndromes, in part because of increased platelet …
cardiovascular events after acute coronary syndromes, in part because of increased platelet …
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
G Montalescot, P Barragan, O Wittenberg… - … England Journal of …, 2001 - Mass Medical Soc
Background When administered in conjunction with primary coronary stenting for the
treatment of acute myocardial infarction, a platelet glycoprotein IIb/IIIa inhibitor may provide …
treatment of acute myocardial infarction, a platelet glycoprotein IIb/IIIa inhibitor may provide …
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus
PR Moreno, AM Murcia, IF Palacios, MN Leon… - Circulation, 2000 - Am Heart Assoc
Background—Lipid-rich, inflamed atherosclerotic lesions are associated with plaque rupture
and thrombosis, which are the most important causes of death in patients with diabetes …
and thrombosis, which are the most important causes of death in patients with diabetes …
[HTML][HTML] Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy
Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …
Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
K Franklin, RJ Goldberg, F Spencer… - Archives of Internal …, 2004 - jamanetwork.com
Background There are limited data describing the presenting characteristics, management,
and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS) …
and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS) …
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Following an ischemic event, diabetic patients have a higher rate of recurrence than patients
without diabetes mellitus. 1–6 Patients with diabetes but without prior myocardial infarction …
without diabetes mellitus. 1–6 Patients with diabetes but without prior myocardial infarction …